This inflammatory state allows cytokines to breach the blood-brain barrier, leading to neuroinflammation, which facilitates the accumulation and reduced clearance of β-amyloid proteins and the aggregation of tau proteins, thereby exacerbating Alzheimer’s disease pathology. This evidence concerns the gene MAPT and early-onset autosomal dominant Alzheimer disease.